Your browser doesn't support javascript.
loading
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Griffin, Gabriel K; Weirather, Jason L; Roemer, Margaretha G M; Lipschitz, Mikel; Kelley, Alyssa; Chen, Pei-Hsuan; Gusenleitner, Daniel; Jeter, Erin; Pak, Christine; Gjini, Evisa; Chapuy, Bjoern; Rosenthal, Michael H; Xu, Jie; Chen, Benjamin J; Sohani, Aliyah R; Lovitch, Scott B; Abramson, Jeremy S; Ishizuka, Jeffrey J; Kim, Austin I; Jacobson, Caron A; LaCasce, Ann S; Fletcher, Christopher D; Neuberg, Donna; Freeman, Gordon J; Hodi, F Stephen; Wright, Kyle; Ligon, Azra H; Jacobsen, Eric D; Armand, Philippe; Shipp, Margaret A; Rodig, Scott J.
Afiliação
  • Griffin GK; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Weirather JL; Department of Data Sciences and.
  • Roemer MGM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Lipschitz M; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Kelley A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Chen PH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Gusenleitner D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Pak C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Gjini E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Chapuy B; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Rosenthal MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Xu J; Department of Hematology and Oncology, University Medical Center, Göttingen, Germany.
  • Chen BJ; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA.
  • Sohani AR; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lovitch SB; Department of Pathology, UMass Memorial Medical Center, Worcester, MA.
  • Abramson JS; Department of Pathology and.
  • Ishizuka JJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Kim AI; Center for Lymphoma, Massachusetts General Hospital, Boston, MA; and.
  • Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • LaCasce AS; Department of Medical Oncology, Yale Cancer Center, New Haven, CT.
  • Fletcher CD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Neuberg D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Hodi FS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Wright K; Department of Data Sciences and.
  • Ligon AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Armand P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Shipp MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Rodig SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood ; 137(10): 1353-1364, 2021 03 11.
Article em En | MEDLINE | ID: mdl-32871584

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfoma Difuso de Grandes Células B / Evasão Tumoral / Receptor de Morte Celular Programada 1 / Histiócitos Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfoma Difuso de Grandes Células B / Evasão Tumoral / Receptor de Morte Celular Programada 1 / Histiócitos Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Marrocos